Endotoxin Removal in Septic Shock with the Alteco LPS Adsorber Was Safe But Showed no Benefit Compared to Placebo in the Double-Blind Randomized Controlled Trial—the Asset Study
Authors:
- 26 December 2019
- journal article
- research article
- Published by Wolters Kluwer Health in Shock
- Vol. 54 (2) , 224-231
Abstract
Purpose: Lipopolysaccharides (LPS) are presumed to contribute to the inflammatory response in sepsis. We investigated if extracorporeal Alteco LPS Adsorber for LPS removal in early gram-negative septic shock was feasible and safe. Also, effects on endotoxin level, inflammatory response, and organ function were assessed. Methods: A pilot, double-blinded, randomized, Phase IIa, feasibility clinical investigation was undertaken in six Scandinavian intensive care units aiming to allocate 32 septic shock patients with abdominal or urogenital focus on LPS Adsorber therapy or a Sham Adsorber, therapy without active LPS binding. The study treatment was initiated within 12 h of inclusion and given for 6 h daily on first 2 days. LPS was measured in all patients. Results: The investigation was terminated after 527 days with eight patients included in the LPS Adsorber group and seven in the Sham group. Twenty-one adverse effects, judged not to be related to the device, were reported in three patients in the LPS Adsorber group and two in the Sham group. Two patients in the Sham group and no patients in the LPS Adsorber group died within 28 days. Plasma LPS levels were low without groups differences during or after adsorber therapy. The changes in inflammatory markers and organ function were similar in the groups. Conclusions: In a small cohort of patients with presumed gram-negative septic shock, levels of circulating endotoxin were low and no adverse effects within 28 days after LPS adsorber-treatment were observed. No benefit compared with a sham device was seen when using a LPS adsorber in addition to standard care. Trial registration: Clinicaltrials.gov NCT02335723. Registered: November 28, 2014.Keywords
This publication has 27 references indexed in Scilit:
- A New Endotoxin Adsorber in Septic Shock: Observational Case SeriesBlood Purification, 2011
- The Sequential Organ Failure Assessment score for predicting outcome in patients with severe sepsis and evidence of hypoperfusion at the time of emergency department presentation*Critical Care Medicine, 2009
- Inflammatory and circulatory effects of the reduction of endotoxin concentration in established porcine endotoxemic shock—A model of endotoxin eliminationCritical Care Medicine, 2009
- Septic shockThe Lancet, 2005
- The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failureIntensive Care Medicine, 1996
- Antibiotic-induced release of endotoxin from bacteria in vitroJournal of Medical Microbiology, 1994
- A New Simplified Acute Physiology Score (SAPS II) Based on a European/North American Multicenter StudyJAMA, 1993
- Definitions for Sepsis and Organ Failure and Guidelines for the Use of Innovative Therapies in SepsisChest, 1992
- The Cardiovascular Response of Normal Humans to the Administration of EndotoxinNew England Journal of Medicine, 1989
- Plasma Endotoxin as a Predictor of Multiple Organ Failure and Death in Systemic Meningococcal DiseaseThe Journal of Infectious Diseases, 1989